Legs
75% clearance
For adults and children 12+ years with moderate to severe eczema (atopic dermatitis) that did not respond to previous treatment and their eczema is not well controlled using other pills or injections, including biologics, or the use of other pills or injections is not recommended.
This is what RINVOQ relief can look like
Check out skin clearance on multiple patients and parts of the body. Just select an image below and drag the slider. Read more about RINVOQ results—including itch relief—here.
Arms
75% clearance
Back
90% clearance
Ankles/Feet
75% clearance
Legs
75% clearance
Arms
75% clearance
Back
90% clearance
Ankles/Feet
90% clearance
Talking to my rheum
Music track and RINVOQ logo throughout.
ANNA: When I went to my rheumatologist, as soon as I walked in the door she said, “I see you're here to talk about psoriatic arthritis.”
So, she ran my bloods, ran the X-rays. She said, “I'm going to write you a prescription and we're going to send this right off.”
You could tell she cared.
So it was working really well, and then—not so well. HUMIRA did not help my psoriatic arthritis symptoms enough. I still had really swollen joints.
When you’ve been through the process of finding a doctor that listens, it’s hard to stand up and say, “It’s not working.”
I felt terrible going to her and telling her that. But like I was telling her, “I'm disappointed with all the work you did.” But she did not take it that way.
So, she told me about RINVOQ.
It’s not an injection—you take it as a pill every day. I was excited.
I’m about a year out, since starting RINVOQ, and my knees don’t hurt as much. My fatigue levels are low enough.
There’s no need to settle. You need to keep advocating for yourself.
ANNOUNCER VOICE-OVER (AVO):
SAFETY CONSIDERATIONS
RINVOQ may cause serious side effects, including:
- Serious infections. RINVOQ can lower ability to fight infections. Serious infections, some fatal, occurred, including tuberculosis (TB) and infections caused by bacteria, fungi, or viruses.
- Increased risk of death in people age 50+ with at least 1 heart disease risk factor.
- Cancer and immune system problems. Increased risk of some cancers, including lymphoma and skin. Current or past smokers have higher risk for lymphoma and lung cancer.
- Increased risk of major cardiovascular events such as heart attack, stroke, or death in people 50+ with at least 1 heart disease risk factor, especially in current or past smokers.
- Blood clots, some fatal, in veins of the legs or lungs and arteries. This occurred more often in people 50+ with at least 1 heart disease risk factor.
- Serious allergic reactions. Do not take if allergic to RINVOQ or its ingredients.
- Tears in the stomach or intestines; changes in certain laboratory test results.
Please see additional Important Safety Information on this webpage.
Legs
75% clearance
Torso
75% clearance
Select Important Safety Information
RINVOQ may cause serious side effects, including:
- Serious Infections, Cancer and Immune System Problems, and Blood Clots.
- Increased risk of death in people age 50+ with at least 1 heart disease risk factor.
- Increased risk of major cardiovascular events, such as heart attack, stroke, or death in people age 50+ with at least 1 heart disease risk factor, especially in current or past smokers.
- Serious allergic reactions. Do not take if allergic to RINVOQ or its ingredients.
Safety Considerations
RINVOQ may cause serious side effects, including:
- Serious infections. RINVOQ can lower ability to fight infections. Serious infections, some fatal, occurred, including tuberculosis (TB) and infections caused by bacteria, fungi, or viruses.
- Increased risk of death in people age 50+ with at least 1 heart disease risk factor.
- Cancer and immune system problems. Increased risk of some cancers, including lymphoma and skin. Current or past smokers have higher risk for lymphoma and lung cancer.
- Increased risk of major cardiovascular events such as heart attack, stroke, or death in people 50+ with at least 1 heart disease risk factor, especially in current or past smokers.
- Blood clots, some fatal, in veins of the legs or lungs and arteries. This occurred more often in people 50+ with at least 1 heart disease risk factor.
- Serious allergic reactions. Do not take if allergic to RINVOQ or its ingredients.
- Tears in the stomach or intestines; changes in certain laboratory test results.
Learn more about these and the full Important Safety Information below.
“Having that itch and rash was just really disruptive…Today, my itch and rash are controlled.”
In addition to safety, what other information about RINVOQ would you need before talking to your doctor?
RINVOQ results.
True stories.
Moderate to severe eczema (atopic dermatitis) disrupts the skin—so Cortney and Josh disrupt it back with RINVOQ. Watch their stories to see how they fought itch & rash with this once-daily pill.
SUGGESTED FOR YOU
Savings. Support. RINVOQ for as little as $0 per month for eligible patients.*
*Eligibility: Available to patients with commercial insurance coverage for RINVOQ® (upadacitinib) who meet eligibility criteria. This co-pay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law. Offer subject to change or termination without notice. Restrictions, including monthly maximums, may apply. This is not health insurance. For full Terms and Conditions, visit RINVOQSavingsCard.com or call 1.800.2RINVOQ for additional information. To learn about AbbVie’s privacy practices and your privacy choices, visit https://privacy.abbvie.